I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| retinal cone cell | 7 studies | 63% ± 19% | |
| oligodendrocyte | 5 studies | 26% ± 9% | |
| OFF-bipolar cell | 4 studies | 45% ± 16% | |
| GABAergic neuron | 4 studies | 25% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal cone cell | 7 studies | 63% ± 19% | |
| oligodendrocyte | 5 studies | 26% ± 9% | |
| OFF-bipolar cell | 4 studies | 45% ± 16% | |
| GABAergic neuron | 4 studies | 25% ± 8% |
Insufficient scRNA-seq data for expression of TAFA4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 628.36 | 258 / 258 | 68% | 32.81 | 157 / 230 |
| prostate | 65% | 39.92 | 160 / 245 | 54% | 1.52 | 269 / 502 |
| brain | 86% | 125.53 | 2264 / 2642 | 27% | 0.57 | 193 / 705 |
| stomach | 65% | 504.85 | 232 / 359 | 9% | 0.60 | 27 / 286 |
| ovary | 43% | 39.18 | 78 / 180 | 4% | 0.10 | 17 / 430 |
| intestine | 37% | 33.61 | 360 / 966 | 3% | 0.07 | 14 / 527 |
| lung | 30% | 13.55 | 176 / 578 | 6% | 0.18 | 71 / 1155 |
| bladder | 10% | 12.19 | 2 / 21 | 2% | 0.05 | 8 / 504 |
| esophagus | 7% | 5.95 | 103 / 1445 | 3% | 0.05 | 6 / 183 |
| liver | 1% | 0.61 | 3 / 226 | 9% | 0.85 | 35 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.49 | 3 / 45 |
| uterus | 0% | 0 | 0 / 170 | 5% | 0.12 | 21 / 459 |
| muscle | 4% | 1.18 | 34 / 803 | 0% | 0 | 0 / 0 |
| breast | 1% | 0.47 | 3 / 459 | 3% | 0.08 | 33 / 1118 |
| pancreas | 0% | 0.12 | 1 / 328 | 2% | 0.06 | 4 / 178 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.12 | 2 / 80 |
| skin | 0% | 0.06 | 5 / 1809 | 1% | 0.11 | 5 / 472 |
| spleen | 1% | 0.18 | 2 / 241 | 0% | 0 | 0 / 0 |
| adipose | 1% | 0.20 | 8 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0.06 | 2 / 653 | 0% | 0.00 | 1 / 605 |
| kidney | 0% | 0 | 0 / 89 | 0% | 0.01 | 3 / 901 |
| blood vessel | 0% | 0.08 | 4 / 1335 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.03 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0051930 | Biological process | regulation of sensory perception of pain |
| GO_0042391 | Biological process | regulation of membrane potential |
| GO_0010469 | Biological process | regulation of signaling receptor activity |
| GO_0042554 | Biological process | superoxide anion generation |
| GO_0006909 | Biological process | phagocytosis |
| GO_0048246 | Biological process | macrophage chemotaxis |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005515 | Molecular function | protein binding |
| GO_0048018 | Molecular function | receptor ligand activity |
| Gene name | TAFA4 |
| Protein name | TAFA chemokine like family member 4 Chemokine-like protein TAFA-4 |
| Synonyms | FAM19A4 |
| Description | FUNCTION: Modulates injury-induced and chemical pain hypersensitivity (By similarity). Ligand of FPR1, can chemoattract macrophages, promote phagocytosis and increase ROS release . . |
| Accessions | ENST00000295569.12 ENST00000495737.1 A0A0U1RQN7 C9JUW7 Q96LR4 ENST00000634242.1 |
